Illumina (ILMN) Debt to Equity Ratio

Current and historical debt to equity ratio values for Illumina (ILMN) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $42.446B $2.752B
Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.